Qiaodan Liu

机构：Sun Yat-sen University, Fifth Affiliated Hospital of Sun Yat-sen University · ORCID：0000-0001-8696-3833

发表论文 46 篇 · 总被引 1575 次 · h-index 14

代表论文

• Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial (2022 · Journal of Clinical Oncology · 被引 159)
• Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial (2022 · Journal of Experimental & Clinical Cancer Research · 被引 75)
• Insight of a Metabolic Prognostic Model to Identify Tumor Environment and Drug Vulnerability for Lung Adenocarcinoma (2022 · Frontiers in Immunology · 被引 36)
• Tumor Microbiome in Nasopharyngeal Carcinoma and Its Association With Prognosis (2022 · Frontiers in Oncology · 被引 30)
• Anlotinib as a promising inhibitor on tumor growth of oral squamous cell carcinoma through cell apoptosis and mitotic catastrophe (2021 · Cancer Cell International · 被引 29)
• GSDME has prognostic and immunotherapeutic significance in residual hepatocellular carcinoma after insufficient radiofrequency ablation (2023 · Translational Oncology · 被引 13)